美國交通部長達菲：我們將重新評估開展維護工作的時間。

China released its 2026 national reimbursement drug list (NRDL) and a parallel commercial health insurance innovative drug list, adding 107 medicines to the NRDL, including a record 51 Category I new drugs covering oncology, rare diseases, chronic and psychiatric indications. The NRDL now totals 3,331 products (1,935 Western drugs; 1,396 traditional Chinese medicines) and takes effect Jan. 1, 2027. The commercial list added 12 drugs — including the world’s first solid‑tumor CAR‑T and China’s first hemophilia gene therapy — bringing that list to 28.

Nov 14 — China's Li and Thai Prime Minister Anutin attended a China‑Thailand entrepreneurs' forum in Bangkok. Li said bilateral high-level trust and close leadership communication provide a stable, predictable environment for investment and long-term planning. He noted physical connectivity is strengthening — China‑Thailand railway construction is progressing steadily and the Pinglu Canal has opened to navigation — while trade rules, standards and financial "soft connectivity" are being bolstered to facilitate smoother market integration. Li said economic cooperation is extending from traditional sectors into high-tech and emerging industries, with new business models and investment opportunities for firms.